BPC-157 5mg Dosage for Tissue Repair in Canada

August 17, 2026

7 min read

Contents

Self-administration of unapproved compounds carries risks that are not fully characterised in the published literature.

Shop Now

For a standard BPC-157 5mg vial, the most common dosage for tissue repair is 250 to 500 micrograms injected subcutaneously once or twice daily. In Canada, researchers typically reconstitute the 5mg powder with 2 to 3 mL of bacteriostatic water, then draw 0.1 to 0.15 mL per injection. This yields roughly 166 to 250 mcg per dose, a range supported by rodent studies and anecdotal reports for tendon, ligament, and gut healing.

What Is BPC-157 and How Does It Support Tissue Repair?

BPC-157 is a synthetic peptide derived from a protein found in human gastric juice. It does not occur naturally as a standalone peptide but mimics a protective sequence. The peptide promotes angiogenesis, the formation of new blood vessels, which speeds nutrient delivery to damaged tissue. It also upregulates growth hormone receptors on fibroblasts, the cells that build collagen and extracellular matrix.

In animal models, BPC-157 accelerates healing of torn quadriceps muscles, transected Achilles tendons, and damaged ligaments. A 2011 study in the Journal of Applied Physiology showed that rats given BPC-157 after Achilles tendon transection regained tensile strength faster than controls. Human data is limited to case reports and self-experimentation, but the mechanism is consistent: BPC-157 activates the FAK-paxillin pathway, which controls cell migration and adhesion during wound repair.

BPC-157 5mg Dosage: Exact Numbers and Frequency

The most cited dosage for a 5mg vial is 250 mcg twice daily, for a total of 500 mcg per day. Some protocols use 350 mcg once daily for convenience. For acute injuries, researchers often start with 500 mcg twice daily for the first week, then drop to 250 mcg twice daily for maintenance. The total daily dose rarely exceeds 1,000 mcg because higher amounts do not show linear benefit in animal studies.

Body weight does not significantly alter the dose in research settings. A 70 kg subject and a 100 kg subject typically receive the same absolute dose because BPC-157 acts locally at the injection site and systemically through the bloodstream. For gut healing, oral administration of 500 mcg per day is sometimes used, but subcutaneous injection remains the gold standard for tissue repair.

BPC-157 Reconstitution: Step-by-Step for a 5mg Vial

Reconstituting BPC-157 correctly is critical for accurate dosing. Use bacteriostatic water, not sterile water, because the benzyl alcohol preservative prevents bacterial growth during multi-week use. For a 5mg vial, add 2 mL of bacteriostatic water. This creates a concentration of 2,500 mcg per mL. A 0.1 mL injection then delivers 250 mcg, and a 0.2 mL injection delivers 500 mcg.

To reconstitute, wipe the vial tops with an alcohol swab. Draw 2 mL of bacteriostatic water into a sterile syringe. Insert the needle through the rubber stopper at a 45-degree angle and inject the water slowly down the side of the vial. Do not squirt directly onto the powder. Gently roll the vial between your palms for 30 seconds. Never shake the vial, as vigorous agitation can denature the peptide. The solution should be clear and colorless.

Store the reconstituted BPC-157 in the refrigerator at 2 to 8 degrees Celsius. It remains stable for 30 to 45 days. Do not freeze the solution, as ice crystals can damage the peptide structure. Always use a new sterile syringe and needle for each injection to prevent contamination.

Injection Protocol and Cycle Length for Tissue Repair

Inject BPC-157 subcutaneously into the fatty tissue near the injury site. For a knee injury, inject into the thigh or lower abdomen. For a shoulder injury, the upper arm or abdomen works well. Rotate injection sites daily to avoid localized irritation. Use a 30 or 31 gauge insulin syringe with a 5/16 inch needle for minimal discomfort.

A typical BPC-157 cycle for tissue repair lasts 4 to 6 weeks. Some protocols extend to 8 weeks for severe injuries, but longer cycles do not show additional benefit in animal studies. After 4 weeks, take a 2-week break before starting another cycle if needed. This prevents receptor downregulation and allows the body to reset its natural healing response.

For acute injuries, start BPC-157 within 48 hours of the trauma. For chronic injuries that have not healed for months, a 6-week cycle at 500 mcg per day is more appropriate. Many researchers combine BPC-157 with TB-500, another healing peptide, for synergistic effects on soft tissue. You can read more about that combination in our TB-500 dosage guide for muscle recovery in Canada.

BPC-157 Canada: Sourcing and Legal Considerations

In Canada, BPC-157 is not approved by Health Canada for human use. It is sold as a research chemical, meaning it is intended for laboratory and in vitro studies only. However, many Canadian researchers purchase BPC-157 5mg vials from domestic peptide suppliers for personal research. Prices range from $40 to $80 CAD per 5mg vial, depending on the vendor and purity level.

Shop Now

When buying BPC-157 in Canada, look for third-party testing certificates. Reputable suppliers provide HPLC and mass spectrometry reports showing purity above 98 percent. Avoid vendors that do not disclose testing or that sell BPC-157 in capsules, as oral bioavailability is poor without special formulations. For a comparison of peptide vendors in Toronto, see our article on Semaglutide 5mg pricing and where to buy in Toronto.

Expected Results and Timeline for Tissue Repair

Most researchers report noticeable improvement in pain and mobility within 7 to 10 days of starting BPC-157 at 250 to 500 mcg per day. Full tissue remodeling takes longer, typically 4 to 8 weeks, depending on the injury severity. Tendon and ligament injuries respond faster than cartilage damage because those tissues have better blood supply.

In a 2020 case series published in the World Journal of Gastroenterology, patients with inflammatory bowel disease who received oral BPC-157 showed reduced inflammation markers within 2 weeks. For musculoskeletal injuries, anecdotal reports on forums like Reddit describe reduced stiffness and faster return to activity. However, these are not controlled trials, so results vary widely.

BPC-157 does not cause the dramatic muscle growth seen with anabolic steroids. Its role is to accelerate the body's own repair mechanisms. If you are looking for a peptide that directly stimulates growth hormone release, compare Sermorelin versus Ipamorelin for growth hormone stimulation.

Side Effects and Safety Profile of BPC-157

BPC-157 has a remarkably clean safety profile in animal studies. No lethal dose has been established, and no organ toxicity has been observed at therapeutic doses. The most common side effect in human self-reports is mild injection site redness or itching, which resolves within an hour. Some users report transient nausea when taking BPC-157 orally, but this is rare with subcutaneous use.

Because BPC-157 promotes angiogenesis, there is a theoretical concern that it could accelerate tumor growth. However, no study has demonstrated this effect. Researchers with a history of cancer should avoid BPC-157 until more data is available. Pregnant or nursing women should not use BPC-157, as its effects on fetal development are unknown.

Long-term safety data beyond 8 weeks is lacking. Most researchers limit cycles to 6 weeks and take breaks to minimize unknown risks. If you experience persistent pain, swelling, or signs of infection at the injection site, discontinue use and consult a healthcare professional.

BPC-157 vs Other Healing Peptides: A Quick Comparison

BPC-157 and TB-500 are often used together, but they work differently. TB-500, a fragment of thymosin beta-4, primarily regulates actin, a protein that controls cell movement and division. BPC-157 focuses on angiogenesis and growth factor receptor upregulation. Together, they cover more of the healing cascade than either alone.

GHK-Cu is another peptide that supports tissue repair, but its mechanism is copper-dependent. GHK-Cu binds copper ions and delivers them to damaged tissue, where they act as cofactors for collagen synthesis. BPC-157 does not require copper and works through a different pathway. For a detailed comparison of healing peptides, see our guide on AOD-9604 dosage for fat loss in Quebec, which also covers overlapping mechanisms.

Frequently Asked Questions About BPC-157 5mg Dosage

Can I inject BPC-157 into the injured area directly? Yes, but it is not necessary. Subcutaneous injection near the site is sufficient because BPC-157 enters the bloodstream and travels systemically. Intramuscular injection is not recommended due to increased pain and no added benefit.

How long does a 5mg vial last at 250 mcg twice daily? At 500 mcg per day, a 5mg vial lasts 10 days. If you use 250 mcg once daily, it lasts 20 days. Plan your purchase accordingly. Most researchers buy 3 to 5 vials for a full 6-week cycle.

What is the best time of day to inject BPC-157? There is no circadian rhythm effect for BPC-157. Inject at the same times each day for consistency, such as morning and evening. If using once daily, inject in the morning to align with the body's natural cortisol peak.

Can BPC-157 be taken orally instead of injected? Oral BPC-157 is available, but it requires an acid-resistant capsule to survive stomach acid. For tissue repair outside the gut, subcutaneous injection is more reliable. Oral forms are primarily used for gastrointestinal conditions.